About the Company

In 2005 by personal order of the President of the Republic of Kazakhstan N.A. Nazarbayev phase 1 of “Karagandinskiy pharmatsevticheskiy Komplex” LLC was built and put into operation for production of original medical products.
In 2008 the company started production of the first domestic medical product Arglabin, designed for treating oncology diseases. 
In 2010 the enterprise was included into the governmental Programme of development of the pharmaceutical industry of the Republic of Kazakhstan for 2010 – 2014 and with financial aid of the governmental fund construction of the third phase of “Karagandinskiy pharmatsevticheskiy Komplex” LLC was started . 
In July 2012 a decision was made regarding private investments into the company development, this gave a new impulse to the project implementation.

The project includes:

1. Construction of the administrative and laboratory building with total area of 2500 sq.m, there will be three laboratories of the Quality Assurance Department– physic-chemical, microbiological and biochemical. Laboratories of the QAD will be equipped with required engineering systems for microclimate maintenance, air and water treatment, and advanced laboratory equipment.  Total area of the laboratory premises is 936 sq.m. 
2. Modernization of the department of sterile dosage forms with area of 2300 sq.m. The department will produce drugs in vials, cartridges and prefilled syringes. 
3. Construction of a pharmaceutical storehouse with capacity of 1,500 pallet positions equipped for work in “cold chain” and meeting requirements of Good Distribution Practice (GDP);

The start of the operation of “Karagandinskiy pharmatsevticheskiy Komplex” LLC is planned for    2015. Overall area 
 It is planned to create over 150 new work places.

Development strategy of the “Karagandinskiy pharmatsevticheskiy Komplex” LLC is aimed at introduction of original medical products into production and production of medical products of partner companies.